Market Indices
Latest News
 |
Key Points- Rosen Law Firm reminds Nektar Therapeutics investors of May...April 9, 2026 NKTR 3.69% |
| ||
| ||
| ||
|
Price Targets
Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...
March 18, 2026 CTMX -0.24%
Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,
March 17, 2026 ABEO 5.13%
Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,
March 17, 2026 CTRN 2.03%
Greg Renza from Truist Financial issued a price target of $12.00 for CATX on 2026-03-17 12:35:00.The adjusted price target was set to $12.00.At the time of the announcement,
March 17, 2026 CATX 2.75%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| EOSE Eos Energy Enterprises, I | 5.95
29.63% | ||||||||||||||||||
| RELL Richardson Electronics, L | 14.43
22.70% | ||||||||||||||||||
| SLDPW Solid Power Inc | 0.24
20.00% | ||||||||||||||||||
| AXTI AXT, Inc. | 63.12
18.69% | ||||||||||||||||||
| ARAY Accuray Incorporated | 0.42
18.36% | ||||||||||||||||||
| JSPR Jasper Therapeutics, Inc. | 0.82
16.60% | ||||||||||||||||||
| ONCY Oncolytics Biotech Inc. | 1.04
14.80% | ||||||||||||||||||
| LCUT Lifetime Brands, Inc. | 7.76
14.29% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 2.79%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 29.63%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 0.80%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.09%